会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE
    • 分子遗传学方法治疗和诊断酒精和药物依赖
    • WO2013036721A1
    • 2013-03-14
    • PCT/US2012/054090
    • 2012-09-07
    • UNIVERSITY OF VIRGINIA PATENT FOUNDATIONJOHNSON, Bankole A.
    • JOHNSON, Bankole A.
    • C07K14/705
    • A61K31/4178C12Q1/6883C12Q2600/106C12Q2600/156
    • The present invention provides compositions and methods useful for diagnosing, treating, and monitoring alcohol dependence and disorders and susceptibility to alcohol dependence disorders, as well as drug related dependence and disorders. The present invention also relates to methods and assays useful for determining whether a subject has a predisposition to developing an addictive disease or disorder, determining whether a subject will be responsive to particular treatments, and compositions and methods useful for treating a subject in need of treatment. The present invention also relates to compositions and methods useful for treating subjects having an addictive disease or disorder (or who are predisposed thereto) based on identification of genetic markers indicative of a subject being predisposed to such disease or disorder or being predisposed to responding to treatment thereof.
    • 本发明提供了用于诊断,治疗和监测酒精依赖性和障碍以及对酒精依赖性障碍的易感性以及与药物有关的依赖性和病症的组合物和方法。 本发明还涉及用于确定受试者是否具有发展成瘾性疾病或病症倾向性,确定受试者是否对特定治疗有反应的方法和测定,以及可用于治疗需要治疗的受试者的组合物和方法 。 本发明还涉及用于治疗患有成瘾性疾病或病症(或倾向于患有此类疾病或受体易感患者)的受试者的组合物和方法,其基于识别指示受试者易患这种疾病或病症或倾向于对治疗作出反应的遗传标记 它们。
    • 10. 发明申请
    • SEROTONIN TRANSPORTER GENE AND TREATMENT OF ALCOHOLISM
    • 丝氨酸运输基因和酒精处理
    • WO2010126603A1
    • 2010-11-04
    • PCT/US2010/001273
    • 2010-04-30
    • UNIVERSITY OF VIRGINIA PATENT FOUNDATIONJOHNSON, Bankole A.
    • JOHNSON, Bankole A.
    • C12Q1/68A61K31/4178
    • C12Q1/6883A61K31/4178C12Q2600/106C12Q2600/112C12Q2600/156
    • The gene (SLC6A4) responsible for encoding the serotonin transporter (SERT) has a functional polymorphism at the 5'-regulatory promoter region, which results in two forms, long (L) and short (S). The LL-genotype is hypothesized to play a key role in the early onset of alcohol use. The present invention discloses the differences in treatment and diagnosis based on the L or short genotypes as well as on a single nucleotide polymorphism of the SERT gene, the 3' UTR SNP rs1042173. The present invention demonstrates the efficacy of using the drug ondansetron and similar drugs for treatment based on diagnosing variations in the polymorphisms of the SERT gene and expression and activity of the SERT gene, as well as methods for diagnosing susceptibility to abuse of alcohol and other addiction-related diseases and disorders, for monitoring treatment and/or abuse (addictive behavior), and for determining which treatment should be used.
    • 负责编码血清素转运蛋白(SERT)的基因(SLC6A4)在5'-调节启动子区域具有功能多态性,其形成长(L)和短(S)两种形式。 假设LL型基因型在酒精使用早期发挥关键作用。 本发明公开了基于L或短基因型的治疗和诊断的差异以及SERT基因,3'UTR SNP rs1042173的单核苷酸多态性。 本发明证明了基于诊断SERT基因多态性和SERT基因表达和活性的变化的药物昂丹司琼和类似药物治疗的疗效以及用于诊断酒精滥用和其他成瘾易感性的方法 相关的疾病和障碍,用于监测治疗和/或滥用(成瘾行为),以及用于确定应使用哪种治疗。